Your browser doesn't support javascript.
loading
Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases.
Onodera, Atsushi; Kokubo, Kota; Okano, Mikiko; Onoue, Miki; Kiuchi, Masahiro; Iwamura, Chiaki; Iinuma, Tomohisa; Kimura, Motoko Y; Ebihara, Nobuyuki; Hanazawa, Toyoyuki; Nakayama, Toshinori; Hirahara, Kiyoshi.
Affiliation
  • Onodera A; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; Institute for Advanced Academic Research, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Kokubo K; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Okano M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Onoue M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Kiuchi M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Iwamura C; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Iinuma T; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Chiba University "Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Japan Initiative for World-leading Vaccine Research and Development Centers, Japan Agency for Medi
  • Ebihara N; Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
  • Hanazawa T; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; AMED-CREST, AMED, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Electronic address: tnakayama@faculty.chiba-u.jp.
  • Hirahara K; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; Chiba University "Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Japan Initiative for World-leading Vaccine Research and Development Centers, J
Pharmacol Ther ; 247: 108445, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37201737
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic / Hypersensitivity Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic / Hypersensitivity Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Country of publication: